Amanote Research
Register
Sign In
Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer
doi 10.33696/cancerimmunol.1.002
Full Text
Open PDF
Abstract
Available in
full text
Date
September 23, 2019
Authors
Unknown
Publisher
Scientific Archives LLC
Related search
You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
Cancers
Cancer Research
Oncology
An Introduction to Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Human Cancer
American Journal of Hematology
Hematology
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
Frontiers in Immunology
Allergy
Immunology
Induced Pluripotent Stem (iPS) Cell–derived, Chimeric Antigen Receptor (CAR)-expressing T Cells for Immunotherapy
Science-Business eXchange
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Chimeric Antigen Receptor T Cells for the Treatment of Lymphoma
Annals of Lymphoma
Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells as an “Off-The-Shelf Immunotherapy” for Improvement in Cancer Treatment
Frontiers in Immunology
Allergy
Immunology
Combining the Best of Two Worlds: Highly Flexible Chimeric Antigen Receptor Adaptor Molecules (CAR-adaptors) for the Recruitment of Chimeric Antigen Receptor T Cells
mAbs
Allergy
Immunology
Cd30-Chimeric Antigen Receptor (Car) T Cells for Therapy of Hodgkin Lymphoma (Hl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
